Search Login Register

Varicella Zoster Encephalitis (Encephalitis, Varicella) Summary

Description: Inflammation of brain tissue caused by infection with the varicella-zoster virus (HERPESVIRUS 3, HUMAN). This condition is associated with immunocompromised states, including the ACQUIRED IMMUNODEFICIENCY SYNDROME. Pathologically, the virus tends to induce a vasculopathy and infect oligodendrocytes and ependymal cells, leading to CEREBRAL INFARCTION, multifocal regions of demyelination, and periventricular necrosis. Manifestations of varicella encephalitis usually occur 5-7 days after onset of HERPES ZOSTER and include HEADACHE; VOMITING; lethargy; focal neurologic deficits; FEVER; and COMA. (From Joynt, Clinical Neurology, 1996, Ch 26, pp29-32; Hum Pathol 1996 Sep;27(9):927-38)

Also Known As: Encephalitis, Varicella; Zoster Encephalitis, Varicella; Encephalitis, Varicella Zoster; Encephalitis, Herpes Zoster; Encephalitis, VZ Virus Show All >>

Networked: 18 relevant articles (1 outcomes, 0 trials/studies) for this Disease

Key Drugs and Agents for Varicella Zoster Encephalitis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:

Vidarabine (Vira-A) : 1 outcome in 3 results : FDA 2
Acyclovir (Aciclovir) : 6 results : FDA 51 Generic
DNA (Deoxyribonucleic Acid) : 2 results : IBA
Diphenhydramine (Benadryl) : 2 results : FDA 98 Generic
Chickenpox Vaccine (Vaccine, Varicella) : 1 result : IBA
Thymidine Kinase : 1 result : IBA
Retinaldehyde (Retinal) : 1 result : IBA
Hormones : 1 result : IBA
Carbon Monoxide : 1 result : IBA

Diseases Related to Varicella Zoster Encephalitis

Show All >>

Key Therapies for Varicella Zoster Encephalitis

Efficacy Chart >>